What we are trying to achieve is labour wages and benefits that are comparable to those of our key competitors--transplant companies in the United States--to sort of have a level playing field on that.
When we do our estimations and sit with our labour partners, there is a benefit to operating in Canada because of the health care system. There is a benefit because of our higher productivity in our Canadian plants. But notwithstanding that, we have a gap. We have shared that with our labour partners, and that's the gap we are trying to close. It is not our intent to leave Canadian workers at an income disadvantage versus anybody else; it's simply to bring certain aspects of compensation and benefits to comparable levels.
I have to give our labour partners credit. I think they understand the severity of the economic situation we are facing in our company, and they're committed to working with us to find acceptable solutions to reach these benchmark levels in compensation in benefits and wages.